Articles with "resectable locally" as a keyword



Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.0165

Abstract: Key Points Question Is a response-adapted strategy based on early tumor response to radiotherapy associated with improved survival with a functional larynx in patients with resectable locally advanced hypopharyngeal carcinoma? Findings In this cohort study… read more here.

Keywords: locally advanced; radiotherapy; response adapted; patients resectable ... See more keywords

Neoadjuvant Radiotherapy vs Up-Front Surgery for Resectable Locally Advanced Rectal Cancer

Sign Up to like & get
recommendations!
Published in 2025 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2025.9049

Abstract: Key Points Question What are the outcomes associated with neoadjuvant radiotherapy (NRT) followed by surgery compared with up-front surgery for patients with resectable locally advanced rectal cancer (LARC)? Findings This cohort study including 4099 patients… read more here.

Keywords: surgery; front surgery; neoadjuvant radiotherapy; rectal cancer ... See more keywords

Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Medicine"

DOI: 10.1002/cam4.5684

Abstract: Primary pure mucinous adenocarcinoma (PMA) is a rare type of lung cancer with unique clinical and prognostic features. Previous studies have shown that PMA have more early‐stage cancer compared with other adenocarcinoma (ADC) subtypes. The… read more here.

Keywords: locally advanced; treatment strategies; mucinous adenocarcinoma; adenocarcinoma ... See more keywords

Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer

Sign Up to like & get
recommendations!
Published in 2017 at "Medical Oncology"

DOI: 10.1007/s12032-017-0997-z

Abstract: Gastrectomy with D2 lymphadenectomy plus postoperative chemotherapy is the standard treatment for resectable locally advanced gastric cancer in Japan. However, the prognosis of patients with serosa-positive tumors remains unsatisfactory because of peritoneal recurrence. This study… read more here.

Keywords: advanced gastric; validity neoadjuvant; gastric cancer; resectable locally ... See more keywords

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

Sign Up to like & get
recommendations!
Published in 2019 at "BMC Cancer"

DOI: 10.1186/s12885-019-5889-5

Abstract: BackgroundSeveral new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear.MethodsA survey was distributed to the members of… read more here.

Keywords: resectable borderline; pdac; resectable locally; borderline resectable ... See more keywords

Neoadjuvant SHR-1701 (a bifunctional anti-PD-L1/TGF-βRII agent) combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A phase II trial.

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2025.43.4_suppl.410

Abstract: 410 Background: Neoadjuvant chemotherapy or chemoradiotherapy followed by surgery is the standard of care for resectable locally advanced ESCC. SHR-1701, a new bifunctional fusion protein composed of a monoclonal antibody against PD-L1 fused with the… read more here.

Keywords: shr; trial; chemoradiotherapy; locally advanced ... See more keywords
Photo from wikipedia

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Inflammation Research"

DOI: 10.2147/jir.s395231

Abstract: Purpose Neoadjuvant immunochemotherapy (nICT) for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) has attracted widespread attention recently, whose safety and clinical benefit was observed in clinical researches. This study aimed to develop and validate… read more here.

Keywords: escc patients; locally advanced; neoadjuvant immunochemotherapy; predictor ... See more keywords

Naples Prognostic Score as a Novel Prognostic Prediction Tool for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Inflammation Research"

DOI: 10.2147/jir.s502058

Abstract: Purpose Esophageal squamous cell carcinoma (ESCC) is a highly invasive malignancy with poor prognosis, especially in its locally advanced stages. Recent studies have highlighted the role of inflammation and nutrition in cancer prognosis. The Naples… read more here.

Keywords: esophageal squamous; neoadjuvant therapy; locally advanced; squamous cell ... See more keywords